Cover image of the article: Distribution and Protective Role of HLAB40 in Iranian Patients with Kawasaki Disease; a Report from Southern Iran

Image Credit:Inn J Pediatr

Distribution and Protective Role of HLAB40 in Iranian Patients with Kawasaki Disease; a Report from Southern Iran

Authors

Gholamhossein Ajami1, Khashayar Aflaki2, Behrooz Gharesi-fard3, Mohammad Borzouee4, Hamid Amoozgar5,*
*Corresponding Author: Email: amozgah@sums.ac.ir

Innovative Journal of Pediatrics:Vol. 24, issue 4; 359-364
Published online:May 24, 2014
Article type:Research Article
Received:Oct 07, 2013
Accepted:May 14, 2014
How to Cite:Ajami G, Aflaki K, Gharesi-fard B, Borzouee M, Amoozgar H. Distribution and Protective Role of HLAB40 in Iranian Patients with Kawasaki Disease; a Report from Southern Iran. Inn J Pediatr. 2014;24(4):. doi:

Abstract

Objective: Kawasaki disease (KD) clinically presents as a systemic vasculitis syndrome with significant cardiovascular involvement. With different incidence among different ethnic groups, the role of certain human leukocyte antigens and their products has been considered as a crucial predisposing factor in the immune responses in this disease.Methods: We determined the distribution of human leukocyte antigens type B for 90 Iranian patients with Kawasaki disease in order to evaluate a possible association between these antigens and this disease in our area. We used the polymerase chain reaction (PCR) sequence specific primers (PCR-SSP) technique for antigen typing. Distribution of these antigens for 89 healthy Iranians used as control.Findings: While 7 (3.9%) of our patients were positive for human leukocyte antigen type B 40*, there were 18 (10.1%) subjects from the control group who had this antigen with statistically significant difference between patients and control group (CI= 95%, RR=1.15 and P= 0.02). Data were analyzed by Pearson chi-square test and Fisher's exact test. SPSS version 15 was used for statistical analysis and a P value less than 0.05 considered statistically significantConclusion: The presence of higher frequency of allele type-B40* in the control group may represent a protective role for this antigen with resultant decreased susceptibility to KD in our area.

 

Highlights

References

  • 1.
    References are available on the PDF.

Copyright

© 2014, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

14
Feb
2021
Association of 8p22-23-rs2254546 Genotypes with Coronary Artery Status and Resistance to Intravenous Immunoglobulin in Iranian Children with Kawasaki Disease

Association of 8p22-23-rs2254546 Genotypes with Coronary Artery Status and Resistance to Intravenous Immunoglobulin in Iranian Children with Kawasaki Disease

Mehrnoush Hassas Yeganeh,
Tolue Mahdavi,
Alireza Firoozfar,
Seyed Arman Saeedi,
Armin Shirvani,
Ali Dehghanifard
,et al.

Hassas Yeganeh M, Mahdavi T, Firoozfar A, Saeedi SA, Shirvani A, et al. Association of 8p22-23-rs2254546 Genotypes with Coronary Artery Status and Resistance to Intravenous Immunoglobulin in Iranian Children with Kawasaki Disease. Arch Pediatr Infect Dis. 2021;9(3):e91586. doi: https://doi.org/10.5812/pedinfect.91586

28
Nov
2019
Clinical Characteristics of Kawasaki Disease in Markazi Province, Iran

Clinical Characteristics of Kawasaki Disease in Markazi Province, Iran

Yazdan Ghandi,
Danial Habibi,
Manigeh Kahbazi,
Fatemeh Dorreh,
Maryam Lotfi

Ghandi Y, Habibi D, Kahbazi M, Dorreh F, Lotfi M. Clinical Characteristics of Kawasaki Disease in Markazi Province, Iran. J Compr Ped. 2019;11(1):e85695. doi: https://doi.org/10.5812/compreped.85695

30
Jun
2007
Kawasaki Disease in 159 Iranian Children

Kawasaki Disease in 159 Iranian Children

Mohammad Hassan Moradinejad,
Abdolrazagh Kiani

Moradinejad MH, Kiani A. Kawasaki Disease in 159 Iranian Children. J Compr Ped. 2007;1(1):. doi:

27
Feb
2014
Clinical Characteristics and Outcomes of Iranian Patients With Kawasaki Disease

Clinical Characteristics and Outcomes of Iranian Patients With Kawasaki Disease

Iraj Sedighi,
Mansoureh Biglari,
Mehrnaz Olfat,
Habibollah Yadolahi,
Asadolah Tanasan,
Saadat Torabian

Sedighi I, Biglari M, Olfat M, Yadolahi H, Tanasan A, et al. Clinical Characteristics and Outcomes of Iranian Patients With Kawasaki Disease. J Compr Ped. 2014;5(1):e13971. doi: https://doi.org/10.17795/compreped-13971

31
Dec
2007
Kawasaki Disease (KD) in Iran: A Report of 85 Cases

Kawasaki Disease (KD) in Iran: A Report of 85 Cases

Ahmad Siadati,
Farah Sabouni

Siadati A, Sabouni F. Kawasaki Disease (KD) in Iran: A Report of 85 Cases. J Compr Ped. 2007;1(2):. doi:

More by these authors

Gholamhossein AjamiPubMedScholar
Khashayar AflakiPubMedScholar
Behrooz Gharesi-fardPubMedScholar
Mohammad BorzoueePubMedScholar
Hamid AmoozgarPubMedScholar
Share
Cited by
Metrics